Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry McLarty

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Human Pathology|April 13, 2010
Stromal expression of actin is a marker of aggressiveness in basal cell carcinomaPatrick A Adegboyega, Sarah Rodriguez, Jerry McLarty
Human Pathology|October 6, 2009
Relationship between eosinophils and chronic endometritisPatrick A Adegboyega, Ying Pei, Jerry McLarty
Southern Medical Journal|March 7, 2012
Critical appraisal process: step-by-stepDonna F Timm, Daniel E Banks, Jerry McLarty
International Journal of Cancer|June 29, 2004
IGF-I and breast cancer: a meta-analysisRunhua Shi, Herbert Yu, Jerry McLarty, et al.
The Laryngoscope|July 3, 2013
Improved wound healing of postischemic cutaneous flaps with the use of bone marrow-derived stem cellsMelissa Hu, David Ludlow, J Steven Alexander, et al.
The Breast Journal|September 11, 2013
Commercial insurance triples chances of breast cancer survival in a public hospitalRunhua Shi, Glenn Mills, Jerry McLarty, et al.
Journal of the Medical Library Association : JMLA|August 10, 2013
The effect of a clinical medical librarian on in-patient care outcomesJulia M Esparza, Runhua Shi, Jerry McLarty, et al.
BMC Cancer|April 18, 2015
Effects of payer status on breast cancer survival: a retrospective studyRunhua Shi, Hannah Taylor, Jerry McLarty, et al.
Journal of Neuroinflammation|September 6, 2006
Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosisWilliam A Sheremata, Wenche Jy, Sylvia Delgado, et al.
Journal of Neuroinflammation|July 3, 2007
Saliva soluble HLA as a potential marker of response to interferon-beta 1a in multiple sclerosis: a preliminary studyAlireza Minagar, Irena Adamashvili, Roger E Kelley, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Human Pathology|April 13, 2010
Stromal expression of actin is a marker of aggressiveness in basal cell carcinomaPatrick A Adegboyega, Sarah Rodriguez, Jerry McLarty
Human Pathology|October 6, 2009
Relationship between eosinophils and chronic endometritisPatrick A Adegboyega, Ying Pei, Jerry McLarty
Southern Medical Journal|March 7, 2012
Critical appraisal process: step-by-stepDonna F Timm, Daniel E Banks, Jerry McLarty
International Journal of Cancer|June 29, 2004
IGF-I and breast cancer: a meta-analysisRunhua Shi, Herbert Yu, Jerry McLarty, et al.
The Laryngoscope|July 3, 2013
Improved wound healing of postischemic cutaneous flaps with the use of bone marrow-derived stem cellsMelissa Hu, David Ludlow, J Steven Alexander, et al.
The Breast Journal|September 11, 2013
Commercial insurance triples chances of breast cancer survival in a public hospitalRunhua Shi, Glenn Mills, Jerry McLarty, et al.
Journal of the Medical Library Association : JMLA|August 10, 2013
The effect of a clinical medical librarian on in-patient care outcomesJulia M Esparza, Runhua Shi, Jerry McLarty, et al.
BMC Cancer|April 18, 2015
Effects of payer status on breast cancer survival: a retrospective studyRunhua Shi, Hannah Taylor, Jerry McLarty, et al.
Journal of Neuroinflammation|September 6, 2006
Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosisWilliam A Sheremata, Wenche Jy, Sylvia Delgado, et al.
Journal of Neuroinflammation|July 3, 2007
Saliva soluble HLA as a potential marker of response to interferon-beta 1a in multiple sclerosis: a preliminary studyAlireza Minagar, Irena Adamashvili, Roger E Kelley, et al.
Pageof 3